Quantcast
Last updated on April 18, 2014 at 17:24 EDT

Latest Élan Stories

2013-12-18 16:24:20

DUBLIN, Dec. 18, 2013 /PRNewswire/ -- Perrigo Company plc (NYSE, TASE: PRGO) ("Perrigo") and Elan Corporation, plc ("Elan") today announced that Perrigo has completed the acquisition of Elan in a cash and stock transaction valued on the date of the announcement at approximately US$8.6 billion. The transaction will create a global healthcare company with an industry-leading growth profile and the geographic scale and scope to continue building a truly differentiated business. (Logo:...

2013-10-17 23:19:38

Reportbuyer.com just published a new market research report: Multiple Sclerosis Therapeutics to 2019 - Treatment Diversification, Increasing Efficacy, and Pipeline Innovation Combine to Drive Growth. London (PRWEB) October 17, 2013 Multiple Sclerosis Therapeutics to 2019 - Treatment Diversification, Increasing Efficacy, and Pipeline Innovation Combine to Drive Growth Summary GBI Research, the leading business intelligence provider, has released its latest research, “Multiple Sclerosis...

2013-05-13 20:22:14

NEW YORK, May 13, 2013 /PRNewswire/ -- Cadwalader, Wickersham & Taft LLP, a leading counselor to global financial institutions and corporations, announced today that client Elan Corporation, plc, a biotechnology company headquartered in Ireland, will purchase from Theravance, Inc. a 21% participation interest in potential future royalty payments related to four respiratory programs partnered with GlaxoSmithKline plc: RELVAR(TM) ELLIPTA(TM)/BREO(TM) ELLIPTA(TM), AORO(TM)...

2013-05-02 08:36:57

Offer Price Reflects $1 Billion Dutch AuctionStrikePrice of $11.25 per Elan Share NEW YORK, May 2, 2013 /PRNewswire/ -- Echo Pharma Acquisition Limited ("Royalty Pharma") has today issued an offer document dated 2 May 2013 (the "Offer Document"). In the Offer Document, Royalty Pharma confirms the Offer Price set forth in its Rule 2.5 Announcement of 15 April (please see the Offer Document for details). The Offer Price reflects Elan's (NYSE: ELN) $1 billion Dutch Auction share...

2013-03-06 08:26:20

This announcement does not constitute an announcement of a firm intention to make an offer under the Irish Takeover Rules NEW YORK, March 6, 2013 /PRNewswire/ -- RP Management, LLC ("Royalty Pharma") remains committed to acquiring Elan (NYSE: ELN) on the terms set out in the Proposal Announcement of February 25, 2013, but continues to be disappointed that the Board of Elan has not engaged in discussions. Royalty Pharma is ready and able to move quickly to implement an offer and...

2013-02-25 04:21:58

Announcement Made Under Rule 2.4 of Irish Takeover Rules NEW YORK, Feb. 25, 2013 /PRNewswire/ -- RP Management, LLC ("Royalty Pharma") today announces that contact was made on Monday February 18, 2013 with the Chairman of the Board of Elan Corporation, plc (NYSE: ELN) ("Elan"), followed by a meeting then taking place on Wednesday February 20, 2013, at which an indicative proposal was made to acquire the entire issued and to be issued share capital of Elan (the "Proposal"). Royalty...

2012-10-11 07:28:22

PITTSBURGH, Oct. 11, 2012 /PRNewswire/ -- Circadiance, the global manufacturer of SleepWeaver soft cloth nasal masks and accessories for PAP users, expands its line of soft cloth masks this week with its full market release of SleepWeaver Elan. "We designed SleepWeaver Elan to satisfy an even wider range of the growing population of sleep apnea patients," explained David Groll, Circadiance President and CEO. "By adding SleepWeaver Elan to our line of soft cloth nasal masks, we're able to...

2012-04-07 23:00:58

New Straight Rail Stair Lift Raises the Bar on Style, Performance & Safety Wilmington, NC (PRWEB) April 07, 2012 The nation´s fastest growing mobility and accessibility provider, 101 Mobility is now offering the Bruno ELAN SRE-3000 throughout its national footprint. The new Straight Rail Stair Lift has raised the bar in style, performance & affordability. The new, innovative Bruno ELAN SRE-3000 offers continuous charge, swivel seat, optional folding rails at landings, a duel...

2012-01-20 15:00:00

MADISON, N.J., Jan. 20, 2012 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced that the U.S. Food and Drug Administration (FDA) has granted a de novo classification petition to its STRATIFY JCV(TM) Antibody ELISA testing service. STRATIFY JCV is the first blood test to be FDA market authorized for the qualitative detection of antibodies to the polyomavirus JC virus (JCV) for stratifying risk for...

2011-12-14 04:00:00

LOS ANGELES, Dec. 14, 2011 /PRNewswire/ -- November 2011 is a record month for Dazadi.com. Dazadi.com's rebranding and focus on home recreation products pays off big. Categories with double-digit sales growth include Sports & Fitness (20%), Game Rooms (91%), Toys & Games (24%), and Backyard & Patio (66%). "I haven't seen this kind of growth in a long time." says Elan Klaristenfeld, Co-Founder and EVP of Marketing. "Clearly our game table category, including foosball...